铁调素 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "铁调素" in Chinese language version.

refsWebsite

Global rank Chinese rank

12nih.gov

4^th place

5^th place

11doi.org

2^nd place

23^rd place

5archive.org

6^th place

4^th place

1rcsb.org

8,838^th place

1,838^th place

archive.org

De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, Kaplan J. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. July 2010, 120 (7): 2395–405. PMC 2898601 . PMID 20530874. doi:10.1172/JCI42011.
Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. May 2009, 75 (9): 976–81. PMID 19212416. doi:10.1038/ki.2009.21.
Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. September 2006, 131 (3): 788–96. PMID 16952548. doi:10.1053/j.gastro.2006.07.007.
Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, Nemeth E, Follenzi A, An X, Mohandas N, Ginzburg Y, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella S. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J. Clin. Invest. December 2010, 120 (12): 4466–77. PMC 2993583 . PMID 21099112. doi:10.1172/JCI41717.
Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin. Chem. December 2011, 57 (12): 1650–69. PMID 21989113. doi:10.1373/clinchem.2009.140053.

doi.org

PDB 1M4F; Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. October 2002, 277 (40): 37597–603. PMID 12138110. doi:10.1074/jbc.M205305200.
Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. August 2003, 102 (3): 783–8. PMID 12663437. doi:10.1182/blood-2003-03-0672.
De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, Kaplan J. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. July 2010, 120 (7): 2395–405. PMC 2898601 . PMID 20530874. doi:10.1172/JCI42011.
Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. May 2009, 75 (9): 976–81. PMID 19212416. doi:10.1038/ki.2009.21.
Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. September 2000, 480 (2–3): 147–50. PMID 11034317. doi:10.1016/S0014-5793(00)01920-7.
Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. March 2001, 276 (11): 7806–10. PMID 11113131. doi:10.1074/jbc.M008922200.
Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. September 2006, 131 (3): 788–96. PMID 16952548. doi:10.1053/j.gastro.2006.07.007.
Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica. January 2008, 93 (1): 90–7. PMID 18166790. doi:10.3324/haematol.11705.
Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am. J. Hematol. February 2013, 88 (2): 97–101. PMID 23335357. doi:10.1002/ajh.23354.
Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, Nemeth E, Follenzi A, An X, Mohandas N, Ginzburg Y, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella S. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J. Clin. Invest. December 2010, 120 (12): 4466–77. PMC 2993583 . PMID 21099112. doi:10.1172/JCI41717.
Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin. Chem. December 2011, 57 (12): 1650–69. PMID 21989113. doi:10.1373/clinchem.2009.140053.

nih.gov

ncbi.nlm.nih.gov

PDB 1M4F; Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. October 2002, 277 (40): 37597–603. PMID 12138110. doi:10.1074/jbc.M205305200.
Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. August 2003, 102 (3): 783–8. PMID 12663437. doi:10.1182/blood-2003-03-0672.
De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, Kaplan J. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. July 2010, 120 (7): 2395–405. PMC 2898601 . PMID 20530874. doi:10.1172/JCI42011.
Rossi E. Hepcidin--the iron regulatory hormone. Clin Biochem Rev. August 2005, 26 (3): 47–9. PMC 1240030 . PMID 16450011.
Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int. May 2009, 75 (9): 976–81. PMID 19212416. doi:10.1038/ki.2009.21.
Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. September 2000, 480 (2–3): 147–50. PMID 11034317. doi:10.1016/S0014-5793(00)01920-7.
Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. March 2001, 276 (11): 7806–10. PMID 11113131. doi:10.1074/jbc.M008922200.
Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben Amor I, Saint-Paul MC, Huet PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. September 2006, 131 (3): 788–96. PMID 16952548. doi:10.1053/j.gastro.2006.07.007.
Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica. January 2008, 93 (1): 90–7. PMID 18166790. doi:10.3324/haematol.11705.
Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am. J. Hematol. February 2013, 88 (2): 97–101. PMID 23335357. doi:10.1002/ajh.23354.
Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, Guy E, Muirhead K, Rao N, Roy CN, Andrews NC, Nemeth E, Follenzi A, An X, Mohandas N, Ginzburg Y, Rachmilewitz EA, Giardina PJ, Grady RW, Rivella S. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J. Clin. Invest. December 2010, 120 (12): 4466–77. PMC 2993583 . PMID 21099112. doi:10.1172/JCI41717.
Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin. Chem. December 2011, 57 (12): 1650–69. PMID 21989113. doi:10.1373/clinchem.2009.140053.

rcsb.org

PDB 1M4F; Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. October 2002, 277 (40): 37597–603. PMID 12138110. doi:10.1074/jbc.M205305200.